Building on these findings, our study investigated whether somatic inactivation of BRCA1 through promoter deletion or methylation, leading to one inactive somatic copy of the gene, correlates with enhanced survival in breast cancer patients. The gene discussed is BRCA1; the disease is breast carcinoma.